Related Experiment Video

Updated: Jul 12, 2026

Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation
06:04

Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation

Published on: August 8, 2025

SGLT2 inhibitors after transcatheter aortic valve implantation: a systematic review and exploratory meta-analysis

Luigi Spadafora1,2, Marco Bernardi2, Gianmarco Sarto3

  • 1Department of Medical-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Latina, Italy.

International Journal of Cardiology. Heart & Vasculature
|July 11, 2026
PubMed
Abstract

No abstract available in PubMed .

Keywords:
Heart failureSGLT2iSodium–glucose cotransporter-2 inhibitorsTAVITAVRTranscatheter aortic valve implantation

Related Concept Videos

Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...